Literature DB >> 1505933

Collecting duct carcinoma: cytogenetic characterization.

L Füzesi1, M Cober, C Mittermayer.   

Abstract

Most renal cell carcinomas are assigned to either the papillary or clear cell, non-papillary type by morphological and cytogenetic criteria. In rare cases, papillary carcinomas of the kidney have been classified as collecting duct carcinoma because of their medullary localization and the associated hyperplastic and dysplastic epithelial lesions of collecting ducts in the vicinity of the tumour. In this first report on the cytogenetics of collecting duct carcinoma, we describe unique and consistent chromosomal aberrations in three cases. Each of the three tumours showed monosomies for chromosomes 1, 6, 14, 15, and 22. This suggests that collecting duct carcinoma is the third type of kidney tumour whose definition is based on morphological as well as on cytogenetic criteria. It appears to be cytogenetically different from the cortical papillary kidney tumour which exhibits trisomy 17 and tri- or tetrasomy 7, and from the non-papillary renal cell carcinoma which characteristically presents deletion of the short arm of chromosome 3.

Entities:  

Mesh:

Year:  1992        PMID: 1505933     DOI: 10.1111/j.1365-2559.1992.tb00364.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  12 in total

1.  Collecting (Bellini) duct carcinoma of the kidney--clinical, radiologic and immunohistochemical findings.

Authors:  P Dobroński; M Czaplicki; E Koźmińska; R Pykało
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

2.  Is there a role for targeted therapies in the collecting ducts of Bellini carcinoma? Efficacy data from a retrospective analysis of 7 cases.

Authors:  Giuseppe Procopio; Elena Verzoni; Roberto Iacovelli; Maurizio Colecchia; Tullio Torelli; Luigi Mariani
Journal:  Clin Exp Nephrol       Date:  2012-01-26       Impact factor: 2.801

3.  Losses at 3p common deletion sites in subtypes of kidney tumours: histopathological correlations.

Authors:  P Hadaczek; J Podolski; A Toloczko; G Kurzawski; A Sikorski; P Rabbitts; K Huebner; J Lubinski
Journal:  Virchows Arch       Date:  1996-09       Impact factor: 4.064

4.  Renal collecting duct carcinoma in an 8-year-old child.

Authors:  R D Craver; H Correa; J P Crapanzano; S R Kumar; R V Gardner
Journal:  Pediatr Nephrol       Date:  1996-02       Impact factor: 3.714

5.  Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer.

Authors:  M-H Wei; O Toure; G M Glenn; M Pithukpakorn; L Neckers; C Stolle; P Choyke; R Grubb; L Middelton; M L Turner; M M Walther; M J Merino; B Zbar; W M Linehan; J R Toro
Journal:  J Med Genet       Date:  2005-06-03       Impact factor: 6.318

6.  Bellini duct (collecting duct) carcinoma of the kidney.

Authors:  G F Prati; P Dean; M Firpo; P Moscatelli; P Saggin; A Muolo
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

7.  Morphological classification of renal cancer.

Authors:  S Störkel; E van den Berg
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

8.  Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America.

Authors:  Jorge R Toro; Michael L Nickerson; Ming-Hui Wei; Michelle B Warren; Gladys M Glenn; Maria L Turner; Laveta Stewart; Paul Duray; Ousman Tourre; Nirmala Sharma; Peter Choyke; Pamela Stratton; Maria Merino; McClellan M Walther; W Marston Linehan; Laura S Schmidt; Berton Zbar
Journal:  Am J Hum Genet       Date:  2003-05-22       Impact factor: 11.025

9.  The importance of histology and cytogenetics in decision making for renal cell carcinoma.

Authors:  Julia G Garcia; Maria M Picken; Robert C Flanigan
Journal:  World J Urol       Date:  2008-04-08       Impact factor: 4.226

10.  Collecting duct carcinoma of the kidney: an immunohistochemical study of 11 cases.

Authors:  Andrea Vecchione; Tommaso Prayer Galetti; Marina Gardiman; Hideshi Ishii; Enrico Giarnieri; Francesco Pagano; Leonard G Gomella; Carlo M Croce; Raffaele Baffa
Journal:  BMC Urol       Date:  2004-09-09       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.